Its persistent activation in PCa can result in progression, rendering it a worthwhile therapeutic target, with one study finding STAT5A/B gene amplification and increased protein expression in PCa, and to a greater extent, in higher grade, castration-resistant and metastatic disease [20,21]. Here, STAT5A is linked to posterior cortical atrophy.